Theo Melas-Kyriazi is an Operating Executive with SFW Capital Partners. He worked for almost 20 years for Thermo Electron Corporation, now Thermo Fisher Scientific (NYSE: TMO), a globally leading manufacturer of instrumentation, most recently serving as CFO. During his career at Thermo, he also served as Treasurer, VP of Corporate Strategy, and CEO of Thermo Spectra Corporation, a publicly-traded subsidiary of Thermo. Mr. Melas-Kyriazi currently serves as a Director of Valeant Pharmaceuticals International (NYSE: VRX), Helicos BioSciences (NASDAQ: HLCS) and several private companies. He has a B.A. and an MBA from Harvard University. |
 |
 |